Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balovaptan in adults with Autism Spectrum Disorder
NCT01793441Phase 2Completed
- Sponsor
- Roche
- Start
- Sep 2013
- Primary completion
- Sep 2016
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Placebo Arm with Balovaptan Arm (2 arms). Primary endpoints: Social Responsiveness Scale 2 at 12 weeks, Columbia-Suicide Severity Rating Scale at 12 weeks and 1 more. Started Sep 2013; status: completed.
02
Drugs
balovaptan
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01793441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01793441.